Log In
Print
BCIQ
Print
Print this Print this
 

DENVax (Dengue fever vaccine) (TAK-003)

  Manage Alerts
Collapse Summary General Information
Company Takeda Pharmaceutical Co. Ltd.
DescriptionRecombinant tetravalent attenuated live dengue vaccine
Molecular Target
Mechanism of ActionVaccine
Therapeutic ModalityPreventive vaccine: Viral vaccine
Latest Stage of DevelopmentPhase II
Standard IndicationDengue fever
Indication DetailsVaccinate against dengue fever
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today